DNA Hypermethylation in Taiwanese Patients with Non-small Cell Lung Cancer
碩士 === 臺灣大學 === 臨床醫學研究所 === 95 === Background Lung cancer is the major cause of cancer-related death in Taiwan and worldwide. Lung cancer accounted for 19.7% of all cancer deaths in 2006 in Taiwan, and 20% to 30% worldwide. About 80% to 85% of all lung cancers are non-small-cell cancer (NSCLC), with...
Main Authors: | Tzer-yueh Wu, 吳則樂 |
---|---|
Other Authors: | Chong-Jen Yu |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/55437430084723976221 |
Similar Items
-
Concomitant hypermethylation of multiple genes in non-small cell lung cancer (NSCLC)
by: Peng Hou, et al.
Published: (2011-04-01) -
Gender difference in the role of promoter hypermethylation and loss of heterozygosity in p16INK4a inactivation among Taiwanese non-small cell lung cancer
by: Min-Chih Hsu, et al.
Published: (2002) -
Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
by: Robert Milewski, et al.
Published: (2009-12-01) -
The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
by: Ya-Sian Chang, et al.
Published: (2021-03-01) -
Promoter DNA hypermethylation leads to Reelindown regulation in cancer cells
by: GUO-YU, LI, et al.
Published: (2012)